Recreational marijuana grabs plenty of headlines. And why shouldn’t it? It’s an industry that will soon be worth hundreds of billions, and let’s face it, there’s still an element of novelty and shock value there.
But make no mistake: Medical marijuana is a growing industry too, and it’s a big one. Global Market Insights predicts the medical cannabis market in the United States alone will be worth more than $8 billion by 2024 – a figure that, in my view, is conservative.
Markets large and… not quite so large, like like Florida and Nebraska, are actively looking to expand their medical marijuana industries to serve more people, in more ways, and in more places.
And as these new laws are being proposed and passed – and the markets expand – we can expect to see some select cannabis stocks rally.
These companies sport leadership with an uncommon vision, who see the undeniable upside in serving both market segments – recreational and medical.
It’s a win-win strategy for them – and a huge boost for investors’ bottom lines.
About the Author
Michael A. Robinson is one of the top financial analysts working today. His book “Overdrawn: The Bailout of American Savings” was a prescient look at the anatomy of the nation’s S&L crisis, long before the word “bailout” became part of our daily lexicon. He’s a Pulitzer Prize-nominated writer and reporter, lauded by the Columbia Journalism Review for his aggressive style. His 30-year track record as a leading tech analyst has garnered him rave reviews, too. Today he is the editor of the monthly tech investing newsletter Nova-X Report as well as Radical Technology Profits, where he covers truly radical technologies – ones that have the power to sweep across the globe and change the very fabric of our lives – and profit opportunities they give rise to. He also explores “what’s next” in the tech investing world at Strategic Tech Investor.
This post is from MoneyMorning. We encourage our readers to continue reading the full article from the original source here.